New genetic links to coronary artery calcification uncovered, offering treatment insights

A new sol­id tu­mor biotech based on re­search out of Stan­ford Uni­ver­si­ty is tar­get­ing the red-hot fields of can­cer im­munother­a­py and an­ti­body-drug con­ju­gates. TwoStep Ther­a­peu­tics

The team at Sea­port Ther­a­peu­tics, a Boston neu­ropsy­chi­a­try biotech, is hav­ing a good fall sea­son. Sea­port said Mon­day it has pieced to­geth­er $225 mil­lion from